InformEx 2014 Kicks Off in Miami Beach - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

InformEx 2014 Kicks Off in Miami Beach


InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center. The conference continues through Jan. 24, featuring on-site education sessions and daily networking events geared toward helping attendees grow their business and prepare for the changing marketplace.

More than 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical companies are taking part in the conference. On-floor education sessions allow attendees to learn about key topics such as green chemistry, opportunities in pharma, personalized medicine, compliance, 3-D printing and more.
Kicking off the conference sessions on Jan. 22 will be a special presentation by Dr. Donna Nelson, University of Oklahoma organic chemistry professor who was a scientific consultant for the Emmy-winning series "Breaking Bad" since its second season. Dr. Nelson will share stories of how she turned her chemistry knowledge into plot-enhancing details for what has been one of the most successful shows of the last decade.


Source: InformEx

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here